Form 8-K - Current report:
SEC Accession No. 0001193125-20-225721
Filing Date
2020-08-20
Accepted
2020-08-20 17:03:02
Documents
12
Period of Report
2020-08-20
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d74525d8k.htm   iXBRL 8-K 27642
  Complete submission text file 0001193125-20-225721.txt   151498

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA anab-20200820.xsd EX-101.SCH 3075
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE anab-20200820_lab.xml EX-101.LAB 18138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anab-20200820_pre.xml EX-101.PRE 11411
5 EXTRACTED XBRL INSTANCE DOCUMENT d74525d8k_htm.xml XML 3407
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 201120728
SIC: 2834 Pharmaceutical Preparations